◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Morishita Jintan Co., Ltd. (4524) Financial History

Name: Morishita Jintan Co., Ltd. (4524) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Morishita Jintan Co., Ltd. (4524) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chuo, Japan with about 359 employees. Its market capitalization is roughly JPY 9 billion. In the fiscal year ended 2026-03-31, 4524 reported JPY 12.7B in revenue and JPY 628M in net income.

Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health food in Japan. The company offers health food products, oral care products, and medical supplies under the JINTAN brand.

Interactive charts & full statements →

4524 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 12.7B	JPY 12.8B	JPY 12.4B	JPY 11.4B	—
Gross Profit	JPY 6.1B	JPY 6.0B	JPY 6.0B	JPY 5.3B	—
Operating Income (EBIT)	JPY 697M	JPY 809M	JPY 720M	JPY 574M	—
Net Income	JPY 628M	JPY 547M	JPY 697M	JPY 491M	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4524 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 224M)	(JPY 204M)	(JPY 163M)	(JPY 152M)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4524 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 18.6B	JPY 17.9B	JPY 17.2B	JPY 16.1B
Total Liabilities	JPY 5.6B	JPY 5.7B	JPY 5.0B	JPY 4.7B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4524 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

IPN · Ipsen S.A. — $13 billion
4574 · Taiko Pharmaceutical Co.,Ltd. — $13 billion
1681 · Consun Pharmaceutical Group Limited — $12 billion
2627 · Ab&B Bio-Tech CO., LTD. JS — $12 billion
4512 · Wakamoto Pharmaceutical Co.,Ltd. — $9 billion
2186 · Luye Pharma Group Ltd. — $8 billion
0460 · Sihuan Pharmaceutical Holdings Group Ltd. — $8 billion
APTX · Apotex Health Corp. — $8 billion

← 4523 All “0-9” companies 4526 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.